These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17465236)
1. Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma. Vuento M; Salmi T; Klemi P; Grénman S Anticancer Res; 2007; 27(2):1015-8. PubMed ID: 17465236 [TBL] [Abstract][Full Text] [Related]
2. The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer. Engblom PR; Grènman SE; Klemi PJ; Hirvonen TE; Rantanen VT; Salmi TA Acta Oncol; 1995; 34(6):783-5. PubMed ID: 7576746 [TBL] [Abstract][Full Text] [Related]
3. Role of cul-de-sac aspiration cytology in the management and follow-up of patients with ovarian carcinoma. A preliminary report. Goldberg G; Learmonth G; Bloch B; Levin W J Reprod Med; 1985 Nov; 30(11):867-70. PubMed ID: 4078821 [TBL] [Abstract][Full Text] [Related]
4. Pervaginal cul-de-sac cytology and CT in the follow-up care of patients with advanced ovarian cancer. Venesmaa P; Vesterinen E; Kivisaari L; Nieminen U Gynecol Oncol; 1986 Sep; 25(1):84-8. PubMed ID: 3732922 [TBL] [Abstract][Full Text] [Related]
5. [Relevance of cul-de-sac puncture to diagnosis and differentiation of ovarian tumours (author's transl)]. Georgakopoulos PA; Deimezis SM; Lekou S Zentralbl Gynakol; 1981; 103(21):1294-300. PubMed ID: 7324632 [TBL] [Abstract][Full Text] [Related]
7. Follow-up study of ovarian carcinoma by cytology of cul-de-sac aspirates. VillaSanta U; Jovanovski D Gynecol Oncol; 1980 Aug; 10(1):58-62. PubMed ID: 7399329 [No Abstract] [Full Text] [Related]
8. Florence-Sydney Breast Biopsy Study: sensitivity of ultrasound-guided versus freehand fine needle biopsy of palpable breast cancer. Houssami N; Ciatto S; Ambrogetti D; Catarzi S; Risso G; Bonardi R; Irwig L Breast Cancer Res Treat; 2005 Jan; 89(1):55-9. PubMed ID: 15666197 [TBL] [Abstract][Full Text] [Related]
9. Transvaginal ultrasound-guided fine needle sampling of deep cancer recurrences in the pelvis: usefulness and limitations. Zanetta G; Brenna A; Pittelli M; Lissoni A; Trio D; Riotta S Gynecol Oncol; 1994 Jul; 54(1):59-63. PubMed ID: 8020840 [TBL] [Abstract][Full Text] [Related]
11. Cul-de-sac needle aspiration: its normal and abnormal cytology and its value in the detection of ovarian cancer. Zervakis M; Howdon WM; Howdon A Acta Cytol; 1969 Sep; 13(9):507-14. PubMed ID: 5285246 [No Abstract] [Full Text] [Related]
13. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence]. Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194 [TBL] [Abstract][Full Text] [Related]
14. [Cancer of the ovary: the usefulness of Cul-de-sac aspiration and the level of carcino-embryonic antigen in the peritoneal fluid]. Zylberberg B; Salat-Baroux J; Ravina JH; Demarcourt V; Dormont D J Gynecol Obstet Biol Reprod (Paris); 1982; 11(3):365-70. PubMed ID: 7119382 [TBL] [Abstract][Full Text] [Related]
15. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study. Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834 [TBL] [Abstract][Full Text] [Related]
16. Prospective pilot evaluation of a new needle prototype for endoscopic ultrasonography-guided fine-needle aspiration: comparison of cytology and histology yield. Papanikolaou IS; Adler A; Wegener K; Al-Abadi H; Dürr A; Koch M; Pohl H; Abou-Rebyeh H; Veltzke-Schlieker W; Wiedenmann B; Rösch T Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):342-8. PubMed ID: 18334879 [TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
18. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Teoh D; Monk BJ; Herzog T; Kapp DS; Bell J Gynecol Oncol; 2010 Mar; 116(3):307-11. PubMed ID: 19944452 [TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients. Nanni C; Rubello D; Farsad M; De Iaco P; Sansovini M; Erba P; Rampin L; Mariani G; Fanti S Eur J Surg Oncol; 2005 Sep; 31(7):792-7. PubMed ID: 15893908 [TBL] [Abstract][Full Text] [Related]
20. Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseases. Fujiwara K; Yamauchi H; Yoshida T; Suzuki S; Oda T; Kohno I Gynecol Oncol; 1998 Aug; 70(2):231-5. PubMed ID: 9740696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]